$3.19
N/A
Dern. MÀJ: Sep 30, 4:26 PM
$3.19
N/A
Larimar Therapeutics (LRMR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.38 | $-0.56 | $-0.50 | $-0.41 |
| Actual | $-0.30 | $-0.31 | $-0.73 | $-0.61 |
| Surprise | +21.1% | +44.6% | -46.0% | -48.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.39 | $-0.36 | $-0.36 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.30 | $-0.38 | 21.1 % |
| Q1 | May 14, 2026 | $-0.31 | $-0.56 | 44.6 % |
| Q4 | Mar 19, 2026 | $-0.73 | $-0.50 | -46.0 % |
| Q3 | Nov 5, 2025 | $-0.61 | $-0.41 | -48.8 % |